Cargando…
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
The prevalence of carbapenem-resistant gram-negative bacterial pathogens (CRGNs) has increased dramatically during the last 10 years, but the optimal treatment for CRGN infections is not well established due to the relative scarcity of robust clinical data. The polymyxins remain the most consistentl...
Autores principales: | Lee, Chang-Seop, Doi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189141/ https://www.ncbi.nlm.nih.gov/pubmed/25298904 http://dx.doi.org/10.3947/ic.2014.46.3.149 |
Ejemplares similares
-
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019) -
Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
por: Rivera-Villegas, Hector Orlando, et al.
Publicado: (2023) -
1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study
por: Bassetti, Matteo, et al.
Publicado: (2020) -
The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008) -
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens
por: Thy, Michaël, et al.
Publicado: (2023)